Bone Safety of Dolutegravir-Containing Regimens in People Living with HIV: Results from a Real-World Cohort

OBJECTIVE: Few data exist about the effect of dolutegravir (DTG) on bone mineral density (BMD) in real life. The aim of this study was to determine rates of change in BMD over time in people living with HIV (PLWH) treated with DTG. DESIGN: The SCOLTA project is a multicenter observational study enro...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfanti, Paolo, De Vito, Andrea, Ricci, Elena, Menzaghi, Barbara, Orofino, Giancarlo, Squillace, Nicola, Molteni, Chiara, De Socio, Giuseppe Vittorio, Salomoni, Elena, Celesia, Benedetto Maurizio, Dentone, Chiara, Colombo, Valeria, Madeddu, Giordano
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368553/
https://www.ncbi.nlm.nih.gov/pubmed/32765005
http://dx.doi.org/10.2147/IDR.S260449

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7368553/
https://www.ncbi.nlm.nih.gov/pubmed/32765005
http://dx.doi.org/10.2147/IDR.S260449

Ejemplares similares